| pubmed-article:17561132 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17561132 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17561132 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:17561132 | lifeskim:mentions | umls-concept:C0681698 | lld:lifeskim |
| pubmed-article:17561132 | lifeskim:mentions | umls-concept:C1414461 | lld:lifeskim |
| pubmed-article:17561132 | lifeskim:mentions | umls-concept:C0002045 | lld:lifeskim |
| pubmed-article:17561132 | lifeskim:mentions | umls-concept:C1552081 | lld:lifeskim |
| pubmed-article:17561132 | lifeskim:mentions | umls-concept:C2349099 | lld:lifeskim |
| pubmed-article:17561132 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17561132 | pubmed:dateCreated | 2007-7-13 | lld:pubmed |
| pubmed-article:17561132 | pubmed:abstractText | The GPSM (Gleason, prostate specific antigen, seminal vesicle and margin status) scoring algorithm is a user friendly model for predicting biochemical recurrence following radical retropubic prostatectomy. It was developed from patients who underwent radical retropubic prostatectomy from 1990 to 1993. We investigated the predictive ability of GPSM in the contemporary era. | lld:pubmed |
| pubmed-article:17561132 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17561132 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17561132 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17561132 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17561132 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17561132 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17561132 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:17561132 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:17561132 | pubmed:author | pubmed-author:BluteMichael... | lld:pubmed |
| pubmed-article:17561132 | pubmed:author | pubmed-author:SlezakJeffrey... | lld:pubmed |
| pubmed-article:17561132 | pubmed:author | pubmed-author:BergstralhEri... | lld:pubmed |
| pubmed-article:17561132 | pubmed:author | pubmed-author:LeibovichBrad... | lld:pubmed |
| pubmed-article:17561132 | pubmed:author | pubmed-author:ThompsonR... | lld:pubmed |
| pubmed-article:17561132 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17561132 | pubmed:volume | 178 | lld:pubmed |
| pubmed-article:17561132 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17561132 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17561132 | pubmed:pagination | 459-63; discussion 463 | lld:pubmed |
| pubmed-article:17561132 | pubmed:dateRevised | 2007-10-23 | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:meshHeading | pubmed-meshheading:17561132... | lld:pubmed |
| pubmed-article:17561132 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17561132 | pubmed:articleTitle | Is the GPSM scoring algorithm for patients with prostate cancer valid in the contemporary era? | lld:pubmed |
| pubmed-article:17561132 | pubmed:affiliation | Department of Urology and Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. | lld:pubmed |
| pubmed-article:17561132 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17561132 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17561132 | lld:pubmed |
